ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 64 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,601,549 | +33.2% | 253,069 | 0.0% | 0.43% | +12.1% |
| Q1 2023 | $1,953,693 | +5.0% | 253,069 | 0.0% | 0.38% | +16.2% |
| Q4 2022 | $1,860,057 | +1.5% | 253,069 | -0.6% | 0.33% | -40.4% |
| Q3 2022 | $1,833,000 | -62.8% | 254,569 | -56.0% | 0.55% | -73.7% |
| Q2 2022 | $4,921,000 | -47.0% | 578,260 | -44.1% | 2.09% | -43.9% |
| Q1 2022 | $9,277,000 | -42.8% | 1,034,222 | -11.6% | 3.72% | -50.9% |
| Q4 2021 | $16,207,000 | – | 1,170,212 | – | 7.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
| BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
| Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
| Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
| DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |